MedTrace Logo

A Randomised Controlled Trial Comparing Bone Anchored Hearing Aid With Bonebridge

NCT01858246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2018-01-24

No results posted yet for this study

Summary

The Bonebridge is a new bone conducting implantable hearing aid. The investigators plan to randomize patients to receive either the Bonebridge or a conventional bone conducting hearing device. The investigators will then compare the surgical and audiological outcomes of the two groups.

Conditions

  • Hearing Loss, Conductive
  • Bone Conduction Deafness

Interventions

DEVICE

Bonebridge

DEVICE

Bone Anchored Hearing Aid

Sponsors & Collaborators

  • Ninewells Hospital

    lead OTHER

Principal Investigators

  • Stephen EM Jones · NHS Tayside

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01858246 on ClinicalTrials.gov